
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Showing 26-50 of 99 citing articles:
Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications
Erica Giacobbi, Rita Bonfiglio, Gabriele Rotondaro, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 645-645
Open Access
Erica Giacobbi, Rita Bonfiglio, Gabriele Rotondaro, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 645-645
Open Access
SMYD3 plays a pivotal role in mediating the epithelial-mesenchymal transition process in breast cancer
Wenwen Zhao, Yuan Gao, Yuting Zhu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151363-151363
Closed Access
Wenwen Zhao, Yuan Gao, Yuting Zhu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151363-151363
Closed Access
Triptolide reverses cis‑diamminedichloroplatinum resistance in esophageal squamous cell carcinoma by suppressing glycolysis and causing mitochondrial malfunction
Kui‐Yuan Liu, Jia Liu, Tiebao Meng, et al.
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Open Access
Kui‐Yuan Liu, Jia Liu, Tiebao Meng, et al.
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Open Access
TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms
Nicholas L. Calistri, Tiera Liby, Zhi Hu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nicholas L. Calistri, Tiera Liby, Zhi Hu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epithelial-mesenchymal transition in cancer: A focus on itraconazole, a hedgehog inhibitor
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Beena Thazhackavayal Baby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189279-189279
Open Access
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Beena Thazhackavayal Baby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189279-189279
Open Access
Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives
Caroline Patini Rezende, D. Alves, Luiz Gustavo de Almeida Chuffa, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2025), pp. 54-71
Open Access
Caroline Patini Rezende, D. Alves, Luiz Gustavo de Almeida Chuffa, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2025), pp. 54-71
Open Access
Gravitational Forces and Matrix Stiffness Modulate the Invasiveness of Breast Cancer Cells in Bioprinted Spheroids
Louise Breideband, Kaja Nicole Wächtershäuser, Ryan Sarkar, et al.
Materials Today Bio (2025) Vol. 31, pp. 101640-101640
Open Access
Louise Breideband, Kaja Nicole Wächtershäuser, Ryan Sarkar, et al.
Materials Today Bio (2025) Vol. 31, pp. 101640-101640
Open Access
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
Yang Ou, Kun Zhang, Qiuying Shuai, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yang Ou, Kun Zhang, Qiuying Shuai, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
The SLC26A4-AS1/NTRK2 axis in breast cancer: insights into the ceRNA network and implications for prognosis and immune microenvironment
Mengqiu Lan, Shuang Qin, Jingjing Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Mengqiu Lan, Shuang Qin, Jingjing Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
miR-378d suppresses gastric cancer metastasis by targeting METTL4 to inhibit epithelial-mesenchymal transition
Dajun Xing, Jiapeng Bao, Jiancheng He, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
Dajun Xing, Jiapeng Bao, Jiancheng He, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
Potential mechanisms of intestinal microbes in bone metastasis of breast cancer
Nicky Gile, Luke Johnston
Asia-Pacific Journal of Oncology (2025)
Open Access
Nicky Gile, Luke Johnston
Asia-Pacific Journal of Oncology (2025)
Open Access
The Clinical Relevance of Epithelial-to-Mesenchymal Transition Hallmarks: A Cut-Off-Based Approach in Healthy and Cancerous Cell Lines
Maria Cristina Rapanotti, Elisa Cugini, Maria Giovanna Scioli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3617-3617
Open Access
Maria Cristina Rapanotti, Elisa Cugini, Maria Giovanna Scioli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3617-3617
Open Access
Biomarkers for the detection of circulating tumor cells
Karol Gostomczyk, Magdalena Drozd, Mohammed Dheyaa Marsool Marsool, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 1, pp. 114555-114555
Closed Access
Karol Gostomczyk, Magdalena Drozd, Mohammed Dheyaa Marsool Marsool, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 1, pp. 114555-114555
Closed Access
GSH-Responsive Heterodimeric Dual-Targeted Nanomedicine Modulates EMT to Conquer Paclitaxel-Induced Invasive Breast Cancer Metastasis
Ying Chen, Yao Chen, Hong Xu, et al.
Bioconjugate Chemistry (2025)
Closed Access
Ying Chen, Yao Chen, Hong Xu, et al.
Bioconjugate Chemistry (2025)
Closed Access
Cancer chemoprevention: signaling pathways and strategic approaches
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Periostin-mediated activation of NF-κB signaling promotes tumor progression and chemoresistance in glioblastoma
Yu Shang, Yuxia Liang, Beichen Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yu Shang, Yuxia Liang, Beichen Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
MMP1-induced NF-κB activation promotes epithelial–mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer
Letian Chen, Yinghuan Cen, Keyang Qian, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Letian Chen, Yinghuan Cen, Keyang Qian, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities
Chunyan Yan, Menglu Zhao, Ya-Nan Wei, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 212-229
Open Access | Times Cited: 9
Chunyan Yan, Menglu Zhao, Ya-Nan Wei, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 212-229
Open Access | Times Cited: 9
Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28563-28576
Open Access | Times Cited: 9
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28563-28576
Open Access | Times Cited: 9
Occam’s Razor-Inspired Nb2C delivery platform potentiates breast cancer therapy and inhibits lung metastasis
Xiangping Lin, Zhongjun Li, Shuang Du, et al.
Chemical Engineering Journal (2023) Vol. 464, pp. 142732-142732
Closed Access | Times Cited: 7
Xiangping Lin, Zhongjun Li, Shuang Du, et al.
Chemical Engineering Journal (2023) Vol. 464, pp. 142732-142732
Closed Access | Times Cited: 7
Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectives
Dapeng Wu, Sai Tian, Wenjing Zhu
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 503-515
Closed Access | Times Cited: 7
Dapeng Wu, Sai Tian, Wenjing Zhu
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 503-515
Closed Access | Times Cited: 7
Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer
Junyuan Xie, Li Gan, Bingjian Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Junyuan Xie, Li Gan, Bingjian Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
SORBS1 inhibits epithelial to mesenchymal transition (EMT) of breast cancer cells by regulating PI3K/AKT signaling and macrophage phenotypic polarization
Kai Feng, Ya Di, Meng Han, et al.
Aging (2024)
Open Access | Times Cited: 2
Kai Feng, Ya Di, Meng Han, et al.
Aging (2024)
Open Access | Times Cited: 2
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases
Koichi Ito, Ibuki Harada, Criseyda Martinez, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 3, pp. 946-957
Open Access | Times Cited: 2
Koichi Ito, Ibuki Harada, Criseyda Martinez, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 3, pp. 946-957
Open Access | Times Cited: 2
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p
Lin Chen, Xianfeng Huang, Yuchen Qian, et al.
Radiation Oncology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Lin Chen, Xianfeng Huang, Yuchen Qian, et al.
Radiation Oncology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2